Ladenburg Thalmann Financial Services’s Virtus LifeSci Biotech Products ETF BBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $57K | Sell |
1,301
-170
| -12% | -$7.45K | ﹤0.01% | 3431 |
|
|
2019
Q3 | $53K | Sell |
1,471
-2,250
| -60% | -$81.1K | ﹤0.01% | 3407 |
|
|
2019
Q2 | $153K | Hold |
3,721
| – | – | ﹤0.01% | 2657 |
|
|
2019
Q1 | $167K | Sell |
3,721
-200
| -5% | -$8.98K | ﹤0.01% | 2529 |
|
|
2018
Q4 | $137K | Sell |
3,921
-571
| -13% | -$20K | ﹤0.01% | 2525 |
|
|
2018
Q3 | $204K | Buy |
4,492
+450
| +11% | +$20.4K | ﹤0.01% | 2296 |
|
|
2018
Q2 | $167K | Hold |
4,042
| – | – | ﹤0.01% | 2371 |
|
|
2018
Q1 | $167K | Hold |
4,042
| – | – | ﹤0.01% | 2371 |
|
|
2017
Q4 | $164K | Buy |
4,042
+2
| +0% | +$81 | ﹤0.01% | 2350 |
|
|
2017
Q3 | $168K | Buy |
4,040
+1,200
| +42% | +$49.9K | ﹤0.01% | 2232 |
|
|
2017
Q2 | $113K | Hold |
2,840
| – | – | ﹤0.01% | 2443 |
|
|
2017
Q1 | $107K | Hold |
2,840
| – | – | ﹤0.01% | 2353 |
|
|
2016
Q4 | $93K | Buy |
2,840
+2,170
| +324% | +$71.1K | ﹤0.01% | 2373 |
|
|
2016
Q3 | $22K | Hold |
670
| – | – | ﹤0.01% | 3329 |
|
|
2016
Q2 | $18K | Hold |
670
| – | – | ﹤0.01% | 3402 |
|
|
2016
Q1 | $17K | Hold |
670
| – | – | ﹤0.01% | 3364 |
|
|
2015
Q4 | $21K | Buy |
670
+2
| +0.3% | +$63 | ﹤0.01% | 3181 |
|
|
2015
Q3 | $18K | Hold |
668
| – | – | ﹤0.01% | 3166 |
|
|
2015
Q2 | $23K | Buy |
668
+500
| +298% | +$17.2K | ﹤0.01% | 3134 |
|
|
2015
Q1 | $5K | Buy |
+168
| New | +$5K | ﹤0.01% | 3957 |
|